Meribank Biotech Co (4724.TWO) Stock Price

Meribank Biotech Co Price

CLOSED
10.35
​
Market closed

Revenue has compounded at 19.6% per year over the past 6 years to 471.76 M TWD. Meribank Biotech Co's net margin stands at -17.3%, up from -60.8% several years earlier.

Meribank Biotech Co stock price

Access this data via the Eulerpool API

Meribank Biotech Co business model & stock analysis

Meribank Biotech Co., Ltd. engages in the research and development of stem cell technologies. The company is headquartered in Taipei City, Taipei. The company went IPO on 2023-06-16. The firm is engaged in the provision of cord blood (hematopoietic stem cells) storage and application services, placenta and umbilical cord (mesenchymal stem cells) storage and application services, peripheral blood stem cell storage service and application service, and promotion of stem cell transplantation application, development of new stem cell processing technology and storage application services. The firm also develops allogeneic umbilical cord mesenchymal stem cell manufacturing and therapeutic applications.

Frequently asked questions about Meribank Biotech Co

Converted at the current exchange rate, the Meribank Biotech Co share trades at 0.29 EUR (10.35 TWD).

The revenue cannot currently be calculated for Meribank Biotech Co.

The profit cannot currently be calculated for Meribank Biotech Co.

The P/E ratio cannot be calculated for Meribank Biotech Co at the moment.

The P/S cannot be calculated for Meribank Biotech Co currently.

The Eulerpool Quality Score for Meribank Biotech Co is 3/10.

The ISIN of Meribank Biotech Co is TW0004724000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Meribank Biotech Co is 4724.TWO. The ticker symbol is used to trade Meribank Biotech Co shares on the stock exchange.

Fair ValueTerminal
9.83 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Jun 16, 2023
ISIN
TW0004724000
Cusip
Y5S4D0117
Market capitalization
993.39 M TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.80
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-5.80 %
Last updated Oct 10, 2026, 5:55 PM

Meribank Biotech Co Peer Group

Meribank Biotech Co FIGI

4724:TT (Taipei Stock Exchange) · BBG01GYXSB99